ZHEJIANG CHENG YI PHARMACEUTICAL CO., LTD.

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

603811

CNE100002YC7

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
8.3 ^CNY	+1.10%		+4.27%	-19.96%

Apr. 25	Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 07	Cheng Yi Pharmaceutical Shareholder Boosts Stake in Firm	MT

Zhejiang Cheng Yi Pharma's Shareholder to Unload 5.82% Stake

September 09, 2021 at 04:01 am EDT

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHSE:603811) said shareholder plans to unload 5.82% stake in the company between September 16, 2021 and March 15, 2022.

Latest news about Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Cheng Yi Pharmaceutical Shareholder Boosts Stake in Firm	Feb. 07	MT
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Cheng Yi Pharmaceutical Gains Nod to Market Osteoarthritis Drug Ingredient	23-09-19	MT
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-16	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-16	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-25	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Shenzhen Youli Investment Management Co., Ltd. intends to acquire 5.82% stake in Zhejiang Cheng Yi Pharmaceutical Co., Ltd. from Yan Yiyi for approximately CNY 170 million.	21-09-16	CI
Zhejiang Cheng Yi Pharma's Shareholder to Unload 5.82% Stake	21-09-09	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-19	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-22	CI
Wenzhou Guanhui Enterprise Management Co., Ltd. signed an equity transfer agreement to acquire 27.5% stake in Wenzhou Dongtou District Sincerity Microfinance Co., Ltd. from Zhejiang Cheng Yi Pharmaceutical Co., Ltd. for CNY 24.4 million.	21-03-23	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-28	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-20	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Declares Distribution for the Year 2019, Payable on June 3, 2020	20-05-26	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-27	CI
Certain A Shares of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 15-MAR-2020.	20-03-14	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-28	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-21	CI
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Announces Earnings Guidance for the First Half of 2019	19-07-08	CI

Chart Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Duration

Period

Chart Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

More charts

Zhejiang Cheng Yi Pharmaceutical Co., Ltd is a China-based company principally engaged in the research, development, production and sales of bulk pharmaceutical chemicals of chemical medicine and preparations. The Companyâs products are on the spectrum from arthritis, dieresis to anti-virus and anti-tumor. The main products include bulk pharmaceutical chemicals, injections, capsules, intermediates and others.

Sector

Pharmaceuticals

Calendar

2024-05-16 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG CHENG YI PHARMACEUTICAL CO., LTD.	-19.96%	375M
ELI LILLY AND COMPANY	+26.08%	681B
NOVO NORDISK A/S	+21.85%	556B
JOHNSON & JOHNSON	-4.77%	361B
MERCK & CO., INC.	+16.97%	325B
ABBVIE INC.	+5.69%	285B
ASTRAZENECA PLC	+13.68%	235B
NOVARTIS AG	+3.65%	199B
ROCHE HOLDING AG	-11.12%	189B
PFIZER, INC.	-3.40%	157B